Prescribing Information

By Locacorten Vioform. European Journal of Haematology, 2015

1,572 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review (2019, background): “As for midodrine and fludrocortisone, the risk of supine hypertension has to be considered for droxidopa.(98) Therefore, droxidopa is considered to pose an “acceptable risk without specialized monitoring” during the short term, whereas there is “insufficient evidence” to conclude on the safety of dr”